Abstract 4371069: Adult Congenital Heart Disease and Atrial Fibrillation: A Double Burden on Cardiovascular Outcomes

Y Yara Menassa (Tulane School of Medicine, New Orleans, Louisiana, United States) M Mayana Bsoul (Tulane University, New Orleans, Louisiana, United States) M MOHAMMAD MONTASER ATASI (Tulane University, New Orleans, Louisiana, United States) Y Yishi Jia (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) H Han Feng (School of Chemistry) M Michel Abou Khalil (Tulane, New Orleans, Louisiana, United States) C Christian Massad (Tulane University, New Orleans, Louisiana, United States) G ghassan bidaoui (Tulane University, New Orleans, Louisiana, United States) H Hadi Younes (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) T Tarek Nahle (Augusta University, Augusta, Georgia, United States) C Chanho Lim (Tulane University, New Orleans, Louisiana, United States) A Abboud Hassan (Tulane School of Medicine, New Orleans, Louisiana, United States) Y Yingshuo Liu (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) A Ala' Assaf (Tulane University, New Orleans, Louisiana, United States) A Abdel Hadi El Hajjar (Tulane University, New Orleans, Louisiana, United States) C Charbel Noujaim (Tulane Univeristy, New Orleans, Louisiana, United States) L Lilas Dagher (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) M Mario Mekhael (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) S Swati Rao (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) O Omar Kreidieh (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) A Amitabh Pandey (Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States) J Jamil Borgi (Tulane University School of Medicine, New Orleans, Louisiana, United States) N Nassir Marrouche (Tulane University School of Medicin, New Orleans, Louisiana, United States)

Abstract

Background: With 97% of congenital heart disease (CHD) patients now reaching adulthood, the risk of cardiovascular disease, including atrial fibrillation (AF), is higher compared to the general population. Hypothesis: We hypothesize that AF patients with CHD have worse cardiovascular outcomes compared to those without. Methods: This is a retrospective cohort using the REACHnet database from 2010 to 2019. Kaplan-Meier curves and log-rank test were used to study time-to-death, cardiovascular event and hospitalization. Cox regression was used to adjust for age, sex, BMI, hypertension, and diabetes, CHD as confounders. Chi-square and t-test were used to compare categorical and continuous variables, respectively. Results: In total, 5947 AF subjects were included in our analysis, among which 60 (1.0%) were diagnosed with CHD. Most of our CHD cohort had a left-to-right shunt lesion (n=31, 51.7%). AF patients with CHD were significantly more likely to have hypertension (81.7% vs 42.8%, p <0.0001), diabetes mellitus (40.0% vs 23.3%, p =0.002), chronic kidney disease (23.3% vs 11.9%, p =0.007) and strokes (36.7% vs 8.7%, p <0.0001), and had lower BMI (28.25 + 8.2 vs 31.0 + 8.0 , p =0.007) compared to those without. They were also more frequently on antiarrhythmic drugs (16.7% vs 6.0%, p =0.004) and anticoagulants (68.3% vs 35.4%, p <0.0001). There was no difference between the two groups in terms of age ( p =0.318), sex ( p =0.285) and race ( p =0.450). Kaplan-Meier curves showed a significantly shorter time to stroke ( p <0.0001) (Figure 1E), myocardial infarction ( p <0.0001) (Figure 1D) and congestive heart failure ( p =0.001) (Figure 1C) in the CHD group. Patients with CHD had higher risk of stroke (HR = 2.78, 95% CI 1.75–4.43, p <0.0001), and MI (HR = 2.56, 95% CI 1.43–4.61, p =0.004). There was no significant mortality ( p =0.1) (Figure 1A) or hospitalization difference ( p =0.44) (Figure 1B) between the groups. Conclusion: Our preliminary analysis showed that AF patients with CHD have higher stroke and MI risk compared to those without. There was no difference in mortality, CHF and hospitalization between the two groups. Our results suggest that both CHD and AF may contribute to adverse cardiovascular outcomes.

Article Details

Journal Circulation
Volume / Issue Vol. 152, Issue Suppl_3
Published November 04, 2025
ISSN 0009-7322
Publisher Lippincott Williams & Wilkins

Journal Info

Circulation

Lippincott Williams & Wilkins

ISSN: 0009-7322 Health Sciences

Authors (23)

Y

Yara Menassa

Tulane School of Medicine, New Orleans, Louisiana, United States

M

Mayana Bsoul

Tulane University, New Orleans, Louisiana, United States

M

MOHAMMAD MONTASER ATASI

Tulane University, New Orleans, Louisiana, United States

Y

Yishi Jia

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

H

Han Feng

School of Chemistry

M

Michel Abou Khalil

Tulane, New Orleans, Louisiana, United States

C

Christian Massad

Tulane University, New Orleans, Louisiana, United States

G

ghassan bidaoui

Tulane University, New Orleans, Louisiana, United States

H

Hadi Younes

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

T

Tarek Nahle

Augusta University, Augusta, Georgia, United States

C

Chanho Lim

Tulane University, New Orleans, Louisiana, United States

A

Abboud Hassan

Tulane School of Medicine, New Orleans, Louisiana, United States

Y

Yingshuo Liu

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

A

Ala' Assaf

Tulane University, New Orleans, Louisiana, United States

A

Abdel Hadi El Hajjar

Tulane University, New Orleans, Louisiana, United States

C

Charbel Noujaim

Tulane Univeristy, New Orleans, Louisiana, United States

L

Lilas Dagher

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

M

Mario Mekhael

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

S

Swati Rao

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

O

Omar Kreidieh

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

A

Amitabh Pandey

Tulane Univestiy School of Medicine, New Orleans, Louisiana, United States

J

Jamil Borgi

Tulane University School of Medicine, New Orleans, Louisiana, United States

N

Nassir Marrouche

Tulane University School of Medicin, New Orleans, Louisiana, United States